版本:
中国

BRIEF-Catalyst Pharmaceuticals reports positive data from investigator-sponsored trial of firdapse

March 15 Catalyst Pharmaceuticals Inc:

* Catalyst Pharmaceuticals announces positive data from investigator-sponsored trial of firdapse® in treating musk antibody positive myasthenia gravis

* Catalyst Pharmaceuticals Inc- expects additional data to be presented at upcoming medical congresses in 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐